A carregar...
The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer
Estrogen receptor positive breast neoplasias represent over 70% of diagnosed breast cancers. Depending on the stage at which the tumor is detected, HER2 status and genomic risk, endocrine therapy is combined with either radio, chemo and/or targeted therapy. A growing amount of evidence supports the...
Na minha lista:
| Publicado no: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6694443/ https://ncbi.nlm.nih.gov/pubmed/31440208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00547 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|